Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma.

Abstract

BACKGROUND A recent phase 1/2 clinical trial argued for caution for the use of sulfasalazine in progressive glioblastoma (GBM). However, the study enrolled patients with recurrent or progressive high-grade glioma indicating that patients recruited probably had severe disease. Thus, the study may not accurately reflect the effectiveness of sulfasalazine for… (More)
DOI: 10.4103/0028-3886.128280

Topics

Cite this paper

@article{Takeuchi2014SulfasalazineAT, title={Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma.}, author={Satoru Takeuchi and Kojiro Wada and Kimihiro Nagatani and Naoki Otani and Hideo Osada and Hiroshi Nawashiro}, journal={Neurology India}, year={2014}, volume={62 1}, pages={42-7} }